Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PAZOPANIB Cause Blood thyroid stimulating hormone increased? 64 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 64 reports of Blood thyroid stimulating hormone increased have been filed in association with PAZOPANIB (Pazopanib). This represents 0.3% of all adverse event reports for PAZOPANIB.

64
Reports of Blood thyroid stimulating hormone increased with PAZOPANIB
0.3%
of all PAZOPANIB reports
5
Deaths
13
Hospitalizations

How Dangerous Is Blood thyroid stimulating hormone increased From PAZOPANIB?

Of the 64 reports, 5 (7.8%) resulted in death, 13 (20.3%) required hospitalization.

Is Blood thyroid stimulating hormone increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PAZOPANIB. However, 64 reports have been filed with the FAERS database.

What Other Side Effects Does PAZOPANIB Cause?

Death (3,767) Diarrhoea (2,907) Fatigue (1,883) Nausea (1,879) Malignant neoplasm progression (1,471) Drug ineffective (1,135) Decreased appetite (1,116) Vomiting (1,072) Hypertension (1,004) Malaise (764)

What Other Drugs Cause Blood thyroid stimulating hormone increased?

LEVOTHYROXINE (3,171) PEMBROLIZUMAB (330) LENVATINIB (228) NIVOLUMAB (226) ALEMTUZUMAB (194) CABOZANTINIB S-MALATE (164) AMIODARONE (143) SUNITINIB MALATE (112) SOMATROPIN (91) ATORVASTATIN (71)

Which PAZOPANIB Alternatives Have Lower Blood thyroid stimulating hormone increased Risk?

PAZOPANIB vs PEANUT PAZOPANIB vs PEG INTERFERON PAZOPANIB vs PEG-INTERFERON ALFA 2A PAZOPANIB vs PEGASPARGASE PAZOPANIB vs PEGASYS

Related Pages

PAZOPANIB Full Profile All Blood thyroid stimulating hormone increased Reports All Drugs Causing Blood thyroid stimulating hormone increased PAZOPANIB Demographics